News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Celera Corporation Posts 21 Percent Q3 Revenue Decline, Will Cut 50 Jobs
November 4, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(RTTNews) - Celera Corp. (CRA: News ) Wednesday reported a wider loss for the third quarter, hurt mainly by lower revenues and a decline in gross margin.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
People
MORE ON THIS TOPIC
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 27, 2026
·
5 min read
·
Tristan Manalac
Special edition
Deep Dive: BioSpace Takes On JPM26 in San Francisco
February 27, 2026
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Viatris Will Cut Up to 10% of Global Workforce Over 3 Years
February 26, 2026
·
58 min read
·
BioSpace Editorial Staff
Deals
Boehringer Seeks To Rebalance Immunity With Sitryx Collab Potentially Worth $500M+
February 26, 2026
·
1 min read
·
Tristan Manalac
